Irish pharmaceutical company Elan has appointed Dr Renee Tannenbaum as executive vice president and chief commercial officer.
Elan’s chief executive Kelly Martin said that to be successful the company needed someone with “significant expertise in product launches, sales, marketing, managed markets, product development and commercialisation, alliance management and leadership development”.
Dr Tannenbaum was the head of global commercial operations for Novartis Pharma for the last three years.
Elan shareholders had complained about the lack of marketing experience on the board.
